Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
M
214610
vs
K
KOSPI 200
Over the past 12 months, MiCo BioMed Co Ltd has underperformed KOSPI 200, delivering a return of -42% compared to KOSPI 200's +119% growth.
Stocks Performance
214610 vs KOSPI 200
Performance Gap
214610 vs KOSPI 200
Performance By Year
214610 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
MiCo BioMed Co Ltd
Glance View
MiCo BioMed Co. Ltd. engages in the development, manufacture and sale of in vitro diagnosis medical devices and diagnostic reagents. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-06-22. The firm operates its business through three segments. The Molecular Diagnosis segment mainly manufactures and sells products such as nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips. The Biochemical Diagnosis segment mainly manufactures and supplies products such as complex diagnostics, anemia meters, blood glucose meters, medical devices and strips. The Immunodiagnostic Business segment mainly produces and sells immunodiagnostic devices and immunodiagnostic kits.